13 Aug 2026Open access
DeepAMPNet Predictor: systematic evaluation of a compact sequence-based antimicrobial peptide classifierPublisher siteZenodo (CERN European Organization for Nuclear Research)
UniversitiesSahar B. Hassan
Active, last published 2026
In anesthesia and pain management
Sahar B.
Hassan
Scholar“Research focused on Anesthesia and Pain Management and adjacent fields.”
Assiut University
Claim Your Profile6
H-index
409
Citations
Sahar has not officially claimed their profile. If you are Sahar, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ahar B. Hassan is a researcher working on Anesthesia and Pain Management. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Sahar's work has been cited 409 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Anesthesia and Pain Management×4Sepsis Diagnosis and Treatment×3Anesthesia and Sedative Agents×3Pharmaceutical Practices and Patient Outcomes×3Antibiotic Use and Resistance×3
04 · Where I am
Affiliations
Affiliation on published researchAssiut UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
6 works13 Aug 2026Open access
DeepAMPNet Predictor: systematic evaluation of a compact sequence-based antimicrobial peptide classifierPublisher siteZenodo (CERN European Organization for Nuclear Research)
16 Feb 2026Open access
Investigating the clinical outcomes of prolonged versus intermittent infusion of meropenem in critically ill pediatric patients: a randomized double-blind single-center studyPublisher siteFuture Journal of Pharmaceutical Sciences, Antibiotics Pharmacokinetics and Efficacy
29 Dec 2025Open access1cites
Pharmacogenomics of Sorafenib in Hepatocellular Carcinoma (HCC): A LncRNA-Expression Guided Approach Using UCA1 and MALAT1 for Personalizing Therapy in a 154-Patient CohortPublisher sitePharmaceuticals, Cancer-related molecular mechanisms research
20 Oct 2025Open access1cites
Real-world outcomes and predictive factors in hepatocellular carcinoma patients treated with sorafenib: an 18-month ambispective cohort analysisPublisher siteFuture Journal of Pharmaceutical Sciences, Hepatocellular Carcinoma Treatment and Prognosis
31 Jan 2025Open access3cites
FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and SurvivalPublisher siteInternational Journal of Molecular Sciences, Lymphoma Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Sahar?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you